bri3, a novel gene, participates in tumor necrosis factor-alpha-induced cell death (Q24298778)

Integral membrane protein 2C

GOA release 2020-03-11

1 reference

Biochemical and Biophysical Research Communications

GOA release 2020-03-11

1 reference

Haoquan Wu

1

0 references

author name string

Gang Liu

series ordinal

2

0 references

Changben Li

series ordinal

3

0 references

Shouyuan Zhao

series ordinal

4

0 references

language of work or name

English

0 references

publication date

14 November 2003

0 references

published in

0 references

volume

311

0 references

page(s)

518-24

0 references

issue

2

0 references

cites work

The role of TNF in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

1 reference

7 January 2021

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Resistance to tumor necrosis factor induced apoptosis in vitro correlates with high metastatic capacity of cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Local immunotherapy with rhTNF-alpha mutein induces strong antitumor activity without overt toxicity--a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Inhibition of TNF-induced apoptosis by NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Development of anti-TNF therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Lysosomal destabilization in p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Characterization of tumor necrosis factor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Tumor necrosis factor-alpha increases ATP content in metabolically inhibited L929 cells preceding cell death.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Tumor Necrosis Factor-α Increases the Steady-state Reduction of Cytochromebof the Mitochondrial Respiratory Chain in Metabolically Inhibited L929 Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

The lysosomal system in neuronal cell death: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

TNF-R1 signaling: a beautiful pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Lysosomal involvement in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease)

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2003.10.038

7 January 2021

10.1016/J.BBRC.2003.10.038

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2490413

2490413

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference